Chris R. Dunk
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Research and Treatments
Papers in
-
- Epigenetics and DNA Methylation 1
- ATP Synthase and ATPases Research 1
- Cancer therapeutics and mechanisms 1
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Mark R. Albertella (4 shared papers)Peter A. Harris (5 shared papers)Paul M. Loadman (3 shared papers)Roger M. Phillips (2 shared papers)R. Rampling (1 shared paper)Alshad S. Lalani (1 shared paper)Philip H. Jones (1 shared paper)Chris Twelves (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)Cancer Research (1 paper)
- Partner nations
- United KingdomLatvia
In The Last Decade
Chris R. Dunk
4 papers receiving 139 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 88
- Biotechnology 20
- Biomedical Engineering 52
- Oncology 27
- Toxicology 3
Countries citing papers authored by Chris R. Dunk
This map shows the geographic impact of Chris R. Dunk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris R. Dunk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris R. Dunk more than expected).
Fields of papers citing papers by Chris R. Dunk
This network shows the impact of papers produced by Chris R. Dunk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris R. Dunk. The network helps show where Chris R. Dunk may publish in the future.
Co-authors
The 24 scholars most cited alongside Chris R. Dunk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 98 | |
| 2 | 2009 | 38 | |
| 3 | In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts | 2006 | 6 |
| 4 | The novel hypoxia-targeted anticancer agent AQ4N is not subject to multi-drug resistance mediated by PGP/MDR1 | 2005 | 1 |
| 5 | 2004 | 0 |
About Chris R. Dunk
Chris R. Dunk is a scholar working on Molecular Biology, Cancer Research, Biotechnology, Biomedical Engineering and Organic Chemistry, having authored 5 papers that have together received 143 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (1 paper), ATP Synthase and ATPases Research (1 paper), Cancer therapeutics and mechanisms (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Synthesis and Biological Evaluation (1 paper). The work is most often cited by research in Cancer Research (88 citations), Biotechnology (20 citations), Biomedical Engineering (52 citations), Oncology (27 citations) and Toxicology (3 citations). Chris R. Dunk has collaborated with scholars based in United Kingdom and Latvia. Frequent co-authors include Mark R. Albertella, Peter A. Harris, Paul M. Loadman, Roger M. Phillips, R. Rampling, Alshad S. Lalani, Philip H. Jones, Chris Twelves, Alan Anthoney and N.G. Burnet. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.